Antonio Pacifico

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group
    A Pacifico
    Texas Arrhythmia Institute, Houston 77030, USA
    N Engl J Med 340:1855-62. 1999
  2. ncbi Shocks as predictors of survival in patients with implantable cardioverter-defibrillators
    A Pacifico
    Texas Arrhythmia Institute, Houston 77030, USA
    J Am Coll Cardiol 34:204-10. 1999
  3. ncbi Structural pathways and prevention of heart failure and sudden death
    Antonio Pacifico
    Texas Arrhythmia Institute and Baylor College of Medicine, Scorlock Tower, Suite 620, 6560 Fannin Street, Houston, TX 77030, USA
    J Cardiovasc Electrophysiol 14:764-75. 2003
  4. ncbi Ablation for atrial fibrillation: are cures really achieved?
    Antonio Pacifico
    Texas Arrhythmia Institute, Houston, Texas, USA
    J Am Coll Cardiol 43:1940-2. 2004
  5. ncbi Class I or class III agents for atrial fibrillation: are asking the right question?
    Antonio Pacifico
    Texas Arrhythmia Institute, Houston, Texas 77030, USA
    Pacing Clin Electrophysiol 26:1613-9. 2003
  6. ncbi Alternative energy sources for the ablation of arrhythmias
    Jennifer E Cummings
    Department of Cardiovascular Medicine, Section of Pacing and Electrophysiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Pacing Clin Electrophysiol 28:434-43. 2005

Detail Information

Publications6

  1. ncbi Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group
    A Pacifico
    Texas Arrhythmia Institute, Houston 77030, USA
    N Engl J Med 340:1855-62. 1999
    ..We tested the efficacy and safety of sotalol, a beta-blocker with class III antiarrhythmic effects, for this purpose...
  2. ncbi Shocks as predictors of survival in patients with implantable cardioverter-defibrillators
    A Pacifico
    Texas Arrhythmia Institute, Houston 77030, USA
    J Am Coll Cardiol 34:204-10. 1999
    ..The objective of the study was to determine whether the occurrence of shocks for ventricular tachyarrhythmias during therapy with implantable cardioverter-defibrillators (ICD) is predictive of shortened survival...
  3. ncbi Structural pathways and prevention of heart failure and sudden death
    Antonio Pacifico
    Texas Arrhythmia Institute and Baylor College of Medicine, Scorlock Tower, Suite 620, 6560 Fannin Street, Houston, TX 77030, USA
    J Cardiovasc Electrophysiol 14:764-75. 2003
    ..Device therapy effectively prevents SCD, but whether biventricular pacing-induced remodeling decreases left ventricular mass remains uncertain...
  4. ncbi Ablation for atrial fibrillation: are cures really achieved?
    Antonio Pacifico
    Texas Arrhythmia Institute, Houston, Texas, USA
    J Am Coll Cardiol 43:1940-2. 2004
    ..Randomized controlled trials are needed to confirm postulated long-term cure rates for AF...
  5. ncbi Class I or class III agents for atrial fibrillation: are asking the right question?
    Antonio Pacifico
    Texas Arrhythmia Institute, Houston, Texas 77030, USA
    Pacing Clin Electrophysiol 26:1613-9. 2003
    ..In conclusion, the classification of current antiarrhythmic agents into Class I and III may not be a useful simplification when applied to the pharmacotherapy of AF...
  6. ncbi Alternative energy sources for the ablation of arrhythmias
    Jennifer E Cummings
    Department of Cardiovascular Medicine, Section of Pacing and Electrophysiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Pacing Clin Electrophysiol 28:434-43. 2005